Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12613000322730Phase 3Completed
Phase 3, randomised trial of dextrose in Neonatal hypoglycemia (8 arms), sponsored by The University of Auckland. Primary endpoint: Incidence of neonatal hypoglycaemia. Started Aug 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12613000322730.